![Neil Thompson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Neil Thompson
Vertrieb & Marketing bei POLYPEPTIDE GROUP AG
Vermögen: 41 539 $ am 31.05.2024
Profil
Mr. Neil J.
Thompson is a Director-Global Sales & Marketing at PolyPeptide Group AG.
Mr. Thompson was previously employed as a Product Manager-Peptide by Bachem (U.K.) Ltd., a Product Manager by Bachem AG, and an Assistant Manager-Production by Peninsula Laboratories Europe Ltd.
He received his undergraduate degree from Liverpool John Moores University.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
POLYPEPTIDE GROUP AG
0,00% | 31.12.2023 | 1 122 ( 0,00% ) | 41 539 $ | 31.05.2024 |
Aktive Positionen von Neil Thompson
Unternehmen | Position | Beginn |
---|---|---|
POLYPEPTIDE GROUP AG | Vertrieb & Marketing | 01.01.2022 |
Ehemalige bekannte Positionen von Neil Thompson
Unternehmen | Position | Ende |
---|---|---|
Bachem AG
![]() Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Corporate Officer/Principal | 01.01.2003 |
Bachem (U.K.) Ltd.
![]() Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Corporate Officer/Principal | 01.01.2003 |
Ausbildung von Neil Thompson
Liverpool John Moores University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
POLYPEPTIDE GROUP AG | Health Technology |
Private Unternehmen | 2 |
---|---|
Bachem AG
![]() Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Bachem (U.K.) Ltd.
![]() Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Health Technology |